YaoGeJu

Company directoryChina company filings

HUAZHONG PHARMACEUTICAL CO., LTD.

As of 18 November 2026, for the company name HUAZHONG PHARMACEUTICAL CO., LTD. as recorded, the chemical-drug catalogue lists 25 active records with this name as holder; 53 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

34 acceptance records as first applicant, grouped into 25 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

Sitagliptin and Metformin Hydrochloride Extended-release Tablets 2 records · Latest accepted 2025/12/26

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2504418Generic2025/12/26HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
CYHS2500276Generic2025/01/14HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Doxycycline Hyclate Tablets 1 records · Latest accepted 2025/11/13

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503937Generic2025/11/13HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Ticagrelor Tablets 1 records · Latest accepted 2025/10/22

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503761Generic2025/10/22HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Piracetam Injection 2 records · Latest accepted 2025/08/06

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502825Generic2025/08/06HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
CYHS2502824Generic2025/08/06HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
维生素B6注射液 · No verified English name 1 records · Latest accepted 2025/03/25

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2550157Supplement2025/03/25HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Aspirin Enteric-coated Tablets 1 records · Latest accepted 2025/01/16

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500315Generic2025/01/16HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Lincomycin Injection 1 records · Latest accepted 2024/12/25

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450625Supplement2024/12/25HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Dexamethasone Sodium Phosphate Injection 2 records · Latest accepted 2024/11/28

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450573Supplement2024/11/28HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
CYHB2450572Supplement2024/11/28HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Sacubitril Valsartan Sodium Tablets 3 records · Latest accepted 2024/11/28

Generic · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2404088Generic2024/11/28HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
CYHS2404087Generic2024/11/28HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
CYHS2404086Generic2024/11/28HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Paracetamol Tablets 1 records · Latest accepted 2024/11/01

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2401772Supplement2024/11/01HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Ibuprofen Injection 2 records · Latest accepted 2024/10/29

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHL2400212Generic2024/10/29HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
CYHL2400211Generic2024/10/29HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Amikacin Sulfate injection 1 records · Latest accepted 2024/10/15

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450524Supplement2024/10/15HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Levonorgestrel Tablets 1 records · Latest accepted 2024/08/02

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2450414Supplement2024/08/02HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Pimavanserin Tartrate Capsules 1 records · Latest accepted 2024/02/08

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHL2400037Generic2024/02/08HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Pentoxifylline Injection 1 records · Latest accepted 2023/09/11

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2302437Generic2023/09/11HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Captopril Tablets 1 records · Latest accepted 2023/07/08

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2301524Supplement2023/07/08HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Rocuronium Bromide Injection 2 records · Latest accepted 2023/06/22

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2301680Generic2023/06/22HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
CYHS2301679Generic2023/06/22HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Piracetam Tablets 1 records · Latest accepted 2023/02/08

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2300222Supplement2023/02/08HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
JQL胶囊 · No verified English name 1 records · Latest accepted 2023/01/06

New drug · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2300013New drug2023/01/06HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Levocarnitine Injection 2 records · Latest accepted 2022/09/29

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201640Generic2022/09/29HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
CYHS2201639Generic2022/09/29HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Estazolam Tablets 1 records · Latest accepted 2022/06/23

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2201032Supplement2022/06/23HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Diazepam Tablets 1 records · Latest accepted 2022/03/16

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2250164Supplement2022/03/16HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Benproperlne Ptiospliate Tablets 1 records · Latest accepted 2021/12/22

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2151107Supplement2021/12/22HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Ibuprofen Tablets 2 records · Latest accepted 2021/09/16

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150876Supplement2021/09/16HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
CYHB2150875Supplement2021/09/16HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Metronidazole Tablets 1 records · Latest accepted 2021/09/01

Supplement · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2150846Supplement2021/09/01HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗

Changes in the last 90 days

0 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

  1. No matching records were found in the currently loaded source data; coverage dates are listed below.

Under review

9 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Sitagliptin and Metformin Hydrochloride Extended-release Tablets CYHS2504418Generic2025/12/26HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Doxycycline Hyclate Tablets CYHS2503937Generic2025/11/13HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Ticagrelor Tablets CYHS2503761Generic2025/10/22HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Piracetam Injection CYHS2502825Generic2025/08/06HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Piracetam Injection CYHS2502824Generic2025/08/06HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Aspirin Enteric-coated Tablets CYHS2500315Generic2025/01/16HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Sacubitril Valsartan Sodium Tablets CYHS2404088Generic2024/11/28HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Sacubitril Valsartan Sodium Tablets CYHS2404087Generic2024/11/28HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗
Sacubitril Valsartan Sodium Tablets CYHS2404086Generic2024/11/28HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗

Catalogue holder records

25 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Dexamethasone Sodium Phosphate InjectionHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H420214922026/03/31Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Amikacin Sulfate injectionHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H420214972026/01/20Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Pentoxifylline InjectionHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H202540262025/04/30Generic approved under the new chemical-drug registration classificationCDE ↗
Rocuronium Bromide InjectionHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H202497232024/12/10Generic approved under the new chemical-drug registration classificationCDE ↗
Rocuronium Bromide InjectionHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H202497222024/12/10Generic approved under the new chemical-drug registration classificationCDE ↗
Captopril TabletsHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H202472542024/10/29Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Levocarnitine InjectionHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H202439262024/06/04Generic approved under the new chemical-drug registration classificationCDE ↗
Levocarnitine InjectionHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H202439272024/06/04Generic approved under the new chemical-drug registration classificationCDE ↗
Diazepam TabletsHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H420215282023/07/31Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Benproperlne Ptiospliate TabletsHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H420206042023/07/06Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Ibuprofen TabletsHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H420206062023/01/06Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Ibuprofen TabletsHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H420214082023/01/06Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Metronidazole TabletsHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H420203882022/12/26Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Rifampicin CapsulesHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H420204012022/08/16Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Clindamycin Hydrochloride CapsulesHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H420214712021/10/10Drug that passed quality-and-efficacy consistency evaluationCDE ↗
诺氟沙星胶囊 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H420203982021/07/29Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Estazolam TabletsHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H420215222021/07/05Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Compound Sulfamethoxazole TabletsHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H420224872021/07/01Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Piracetam TabletsHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H420203892021/01/18Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Chlorphenamine Maleate TabletsHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H420206082020/12/11Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Propranolol Hydrochloride TabletsHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H420224882020/10/16Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Cefalexin CapsulesHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H420203902020/09/29Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Captopril TabletsHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H420203842020/07/09Drug that passed quality-and-efficacy consistency evaluationCDE ↗
Lincomycin InjectionHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H420215152026/07/28Drug that passed quality-and-efficacy consistency evaluationCDE ↗
维生素B6注射液 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.HUAZHONG PHARMACEUTICAL CO., LTD.国药准字H202692482026/10/12Drug that passed quality-and-efficacy consistency evaluationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

53 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
蛋白琥珀酸铁 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20250000596I2025/06/20CDE ↗
替格瑞洛 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20240001125A2026/03/12CDE ↗
沙库巴曲缬沙坦钠 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20230001132A2025/08/29CDE ↗
酒石酸匹莫范色林 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20230001160I2023/12/15CDE ↗
对乙酰氨基酚 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190008059A2025/11/01CDE ↗
烟酸 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190007881A2025/06/11CDE ↗
黄体酮 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190007880A2025/06/11CDE ↗
盐酸克林霉素 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190007879A2025/06/11CDE ↗
异烟肼 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190005004A2025/08/30CDE ↗
碘化钾 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190005003A2025/11/01CDE ↗
制霉素 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190005002A2025/11/01CDE ↗
乙酰谷酰胺 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190005001A2025/11/01CDE ↗
卡托普利 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190005000A2025/11/01CDE ↗
盐酸小檗碱 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190004999A2025/11/01CDE ↗
苯丙酸诺龙 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190004998A2025/11/01CDE ↗
丙酸睾酮 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190004997A2025/11/01CDE ↗
甲氧苄啶 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190004996A2025/11/01CDE ↗
甲睾酮 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190004995A2025/11/01CDE ↗
炔诺酮 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190004993A2025/11/01CDE ↗
醋酸曲安萘德 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190004990A2025/11/01CDE ↗
戊酸雌二醇 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190004989A2025/11/01CDE ↗
硝酸硫胺 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190004843A2025/08/27CDE ↗
维生素B1 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190004842A2025/08/27CDE ↗
芬布芬 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190004835A2025/08/30CDE ↗
己酸羟孕酮 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190004834A2025/08/30CDE ↗
劳拉西泮 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190004833A2025/08/30CDE ↗
甘露六烟酯 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190004826A2025/08/30CDE ↗
双炔失碳酯 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003129A2025/06/11CDE ↗
地西泮 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003128A2025/06/11CDE ↗
吡拉西坦 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003125A2025/06/11CDE ↗
阿苯达唑 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003124A2025/06/11CDE ↗
氢化可的松 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003123A2025/11/28CDE ↗
左炔诺孕酮 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003122A2025/06/11CDE ↗
萘普生 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003121A2025/06/11CDE ↗
盐酸林可霉素 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003120A2025/06/11CDE ↗
泼尼松 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003119A2025/11/28CDE ↗
司坦唑醇 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003118A2025/11/28CDE ↗
醋酸可的松 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003117A2025/11/28CDE ↗
硝西泮 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003115A2025/11/28CDE ↗
泼尼松龙 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003114A2025/11/28CDE ↗
布洛芬 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003113A2025/06/11CDE ↗
醋酸泼尼松龙 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003111A2025/11/28CDE ↗
碘酸钾 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003110A2025/06/11CDE ↗
非那西丁 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003109A2025/06/11CDE ↗
醋酸泼尼松 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003108A2025/11/28CDE ↗
烟酰胺 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003104A2025/06/11CDE ↗
肌醇烟酸酯 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003102A2025/06/11CDE ↗
醋酸氢化可的松 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003092A2025/11/28CDE ↗
氯氮卓 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003091A2025/06/11CDE ↗
艾司唑仑 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190003090A2025/06/11CDE ↗
维生素B6 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20190000470A2026/03/27CDE ↗
盐酸普萘洛尔 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20170001428A2024/10/18CDE ↗
盐酸氯氮䓬 · No verified English nameHUAZHONG PHARMACEUTICAL CO., LTD.Y20170001427A2024/10/12CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

1 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
Furosemide Tablets CYHS2300631Generic2023/02/24Hui Yu Yuan He (Hainan) Pharma Co., Ltd. romanized; HUAZHONG PHARMACEUTICAL CO., LTD.CDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.